Pfizer’s lorlatinib has been assigned a “Promising Innovative Medicine” award for the treatment of some patients with ALK-positive advanced non-small cell lung cancer. The drug is currently under review by the European Medicines Agency for patients with the condition who have previously been treated with a second generation ALK tyrosine kinase inhibitor. The PIM award
GlaxoSmithKline (GSK) are constructing their first new manufacturing facility in the UK for nearly forty years, in Ulverston, Cumbria, as part of an investment of over £500 million to increase production of active ingredients. GSK currently hires 15,000 people in the UK with almost 6,000 working in manufacturing. The drugs giant announced today that succeeding
New internet resources supported by the UK’s National Institute for Health Research (NIHR) aim to explain paediatric trials for children and their parents, emphasise informed consent, and inform clinical research professionals about what really matters to young trial participants. The websites have been launched as two new sections of the experiential health websites www.healthtalkonline.org and
The reactions from AstraZeneca’s announcement earlier this week that approximately 7,300 jobs would be cut by the end of 2014 has continued, and it appears that the organisation’s UK research staff will be reduced by between 250 and 350 positions. AstraZeneca, the UK’s second biggest drugs maker, currently employs around 61,000 people globally, 8,000 of
